129 related articles for article (PubMed ID: 37585061)
1. Estimated prevalence of human papillomavirus among Nigerian women: A systematic review and meta-analysis.
Anoruo O; Bristow C; Mody N; Klausner JD
Afr J Reprod Health; 2022 Jun; 26(6):89-96. PubMed ID: 37585061
[TBL] [Abstract][Full Text] [Related]
2. The pattern of human papillomavirus infection and genotypes among Nigerian women from 1999 to 2019: a systematic review.
Emeribe AU; Abdullahi IN; Etukudo MH; Isong IK; Emeribe AO; Nwofe JO; Umeozuru CM; Shuaib BI; Ajagbe ORO; Dangana A; Egenti BN; Ghamba PE
Ann Med; 2021 Dec; 53(1):944-959. PubMed ID: 34124973
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.
Obeid DA; Almatrrouk SA; Alfageeh MB; Al-Ahdal MNA; Alhamlan FS
J Infect Public Health; 2020 Sep; 13(9):1304-1313. PubMed ID: 32564935
[TBL] [Abstract][Full Text] [Related]
4. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
Bruni L; Albero G; Rowley J; Alemany L; Arbyn M; Giuliano AR; Markowitz LE; Broutet N; Taylor M
Lancet Glob Health; 2023 Sep; 11(9):e1345-e1362. PubMed ID: 37591583
[TBL] [Abstract][Full Text] [Related]
5. Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
Pärna K; Nygård M; Tisler A; Toompere K; Naaber P; Ratnik K; Ķīvīte Urtāne A; Zodzika J; Stankūnas M; Baltzer N; Uusküla A
BMJ Open; 2023 Jun; 13(6):e069558. PubMed ID: 37263686
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Type Distribution of Human Papillomavirus Recovered from the Uterine Cervix of Nigerian Women: A Systematic Review and Meta-Analysis.
Kabuga AI; Nejati A; Arero AG; Jalilvand S; Mokhtari-Azad T; Sighaldeh SS; Wali UH; Shahmahmoodi S; El Zowalaty ME
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2837-2846. PubMed ID: 33112538
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis.
Ezechi O; Akinsolu F; Salako A; Abodunrin O; Adewole I; Olagunju M; Okunbor H; Sanni-Adeniyi R; Zamba E; Njuguna DW; Eleje G
J Int Med Res; 2023 Jul; 51(7):3000605231182884. PubMed ID: 37409466
[TBL] [Abstract][Full Text] [Related]
8. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
Ali MAM; Bedair RN; Abd El Atti RM
Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
[TBL] [Abstract][Full Text] [Related]
9. A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.
Ruan Y; Li H; Liu M; Cao G; Xu X; Han L; Li F
Cancer Epidemiol; 2023 Jun; 84():102372. PubMed ID: 37119603
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
[TBL] [Abstract][Full Text] [Related]
11. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
12. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and genotype distribution of human papillomavirus in cervical adenocarcinoma (usual type and variants): A systematic review and meta-analysis.
Reynders C; Lerho T; Goebel EA; Crum CP; Vandenput S; Beaudart C; Herfs M
J Med Virol; 2023 Oct; 95(10):e29190. PubMed ID: 37861377
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human papillomavirus DNA and p16
Li Z; Liu P; Wang Z; Zhang Z; Chen Z; Chu R; Li G; Han Q; Zhao Y; Li L; Miao J; Kong B; Song K
Lancet Oncol; 2023 Apr; 24(4):403-414. PubMed ID: 36933562
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria.
Musa J; Taiwo B; Achenbach C; Olugbenga S; Berzins B; Sagay AS; Idoko JA; Kanki PJ; Murphy RL
Arch Gynecol Obstet; 2013 Dec; 288(6):1365-70. PubMed ID: 23700253
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer in Ethiopia: a review of the literature.
Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
[TBL] [Abstract][Full Text] [Related]
17. High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program.
Sousa H; Tavares A; Campos C; Marinho-Dias J; Brito M; Medeiros R; Baldaque I; Lobo C; Leça L; Monteiro P; Tavares F; Henrique R
Papillomavirus Res; 2019 Dec; 8():100179. PubMed ID: 31377173
[TBL] [Abstract][Full Text] [Related]
18. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
[No Abstract] [Full Text] [Related]
19. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020.
Zhang W; Guo N; Li B; Shang E; Wang J; Zhang M; Yang X
Virol J; 2023 Jan; 20(1):11. PubMed ID: 36653807
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
